↓ Skip to main content

Redefining CD56 as a Biomarker and Therapeutic Target in Multiple Myeloma.

Overview of attention for article published in Molecular Cancer Research, April 2022
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (89th percentile)
  • High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

blogs
2 blogs
twitter
7 X users

Citations

dimensions_citation
10 Dimensions

Readers on

mendeley
11 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Redefining CD56 as a Biomarker and Therapeutic Target in Multiple Myeloma.
Published in
Molecular Cancer Research, April 2022
DOI 10.1158/1541-7786.mcr-21-0828
Pubmed ID
Authors

Francesca Cottini, Jose Rodriguez, Tiffany Hughes, Nidhi Sharma, Ling Guo, Gerard Lozanski, Bei Liu, Emanuele Cocucci, Yiping Yang, Don Benson

X Demographics

X Demographics

The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 11 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 11 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 2 18%
Student > Doctoral Student 2 18%
Other 1 9%
Student > Ph. D. Student 1 9%
Student > Bachelor 1 9%
Other 0 0%
Unknown 4 36%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 4 36%
Medicine and Dentistry 2 18%
Chemistry 1 9%
Unknown 4 36%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 17. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 February 2023.
All research outputs
#2,020,191
of 24,185,663 outputs
Outputs from Molecular Cancer Research
#89
of 1,967 outputs
Outputs of similar age
#46,774
of 432,228 outputs
Outputs of similar age from Molecular Cancer Research
#5
of 52 outputs
Altmetric has tracked 24,185,663 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,967 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.1. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 432,228 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 89% of its contemporaries.
We're also able to compare this research output to 52 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.